NCT00580606View on ClinicalTrials.gov

A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2014

Conditions
Food HypersensitivityHypersensitivityImmediate HypersensitivityPeanut Hypersensitivity
Interventions
DRUG

Glycerinated peanut allergenic extract

Glycerinated peanut extract delivered sublingually.

DRUG

Placebo for peanut extract (glycerin)

Placebo (glycerin) delivered sublingually.

Trial Locations (5)

10029

Mount Sinai School of Medicine, New York

21218

Johns Hopkins University School of Medicine, Baltimore

27706

University of North Carolina, Durham

72202

University of Arkansas, Little Rock

80208

National Jewish Medical and Research Center, Denver

Sponsors
All Listed Sponsors
collaborator

Consortium of Food Allergy Research

OTHER

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH